Colgate-Palmolive (NYSE:CL) Price Target Cut to $107.00 by Analysts at Piper Sandler

Colgate-Palmolive (NYSE:CL) had its target price reduced by Piper Sandler from $108.00 to $107.00 in a research report released on Monday,Benzinga reports. They currently have an overweight rating on the stock.

Other research analysts have also issued research reports about the company. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a research report on Friday, March 14th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, March 25th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Stifel Nicolaus reduced their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Finally, Raymond James restated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $101.78.

Colgate-Palmolive Stock Up 1.1 %

Shares of NYSE:CL opened at $93.84 on Monday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company’s fifty day moving average is $89.80 and its two-hundred day moving average is $93.44. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market capitalization of $76.11 billion, a price-to-earnings ratio of 26.66, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business earned $0.87 EPS. Equities analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive announced that its Board of Directors has authorized a stock buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to reacquire up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Thursday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is 59.09%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth approximately $27,000. Vermillion Wealth Management Inc. acquired a new position in Colgate-Palmolive in the fourth quarter worth approximately $31,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $32,000. Finally, Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $32,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.